NM_000558.5:c.154G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM1BP6_Moderate

The NM_000558.5(HBA1):​c.154G>A​(p.Gly52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000324 in 148,126 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G52R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00051 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HBA1
NM_000558.5 missense

Scores

4
8
6

Clinical Significance

Likely benign criteria provided, single submitter B:2O:1

Conservation

PhyloP100: 0.759

Publications

6 publications found
Variant links:
Genes affected
HBA1 (HGNC:4823): (hemoglobin subunit alpha 1) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA1 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Heinz body anemia
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 29 uncertain in NM_000558.5
BP6
Variant 16-176987-G-A is Benign according to our data. Variant chr16-176987-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 15889.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA1NM_000558.5 linkc.154G>A p.Gly52Ser missense_variant Exon 2 of 3 ENST00000320868.9 NP_000549.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA1ENST00000320868.9 linkc.154G>A p.Gly52Ser missense_variant Exon 2 of 3 1 NM_000558.5 ENSP00000322421.5 P69905

Frequencies

GnomAD3 genomes
AF:
0.000324
AC:
48
AN:
148126
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000503
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000673
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000671
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000280
AC:
39
AN:
139410
AF XY:
0.000315
show subpopulations
Gnomad AFR exome
AF:
0.000132
Gnomad AMR exome
AF:
0.0000403
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000650
Gnomad OTH exome
AF:
0.000239
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000507
AC:
564
AN:
1111556
Hom.:
0
Cov.:
16
AF XY:
0.000453
AC XY:
254
AN XY:
561198
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000267
AC:
7
AN:
26252
American (AMR)
AF:
0.0000534
AC:
2
AN:
37456
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23524
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35316
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35874
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3498
European-Non Finnish (NFE)
AF:
0.000660
AC:
544
AN:
824318
Other (OTH)
AF:
0.000227
AC:
11
AN:
48546
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.372
Heterozygous variant carriers
0
28
56
85
113
141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000324
AC:
48
AN:
148126
Hom.:
0
Cov.:
31
AF XY:
0.000208
AC XY:
15
AN XY:
72142
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000503
AC:
2
AN:
39740
American (AMR)
AF:
0.0000673
AC:
1
AN:
14856
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3422
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5048
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4480
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10280
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000671
AC:
45
AN:
67112
Other (OTH)
AF:
0.00
AC:
0
AN:
1972
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.371
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000791
Hom.:
0
ExAC
AF:
0.000106
AC:
11

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

HBA1-related disorder Benign:1
Feb 17, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jun 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Hb Riccarton variant (HBA1: c.154G>A; p.Gly52Ser, also known as Gly51Ser when numbered from the mature protein, rs33960522, HbVar ID: 1233) is reported in the literature in the heterozygous state in multiple asymptomatic individuals (see HbVar and references therein). This variant was also observed in one individual with alpha (+) thalassemia on the same allele as splice acceptor site variant c.301-2A>T (Scheps 2012). However, the phenotype of this variant in the presence of other alpha globin variants is unknown. This variant is also reported in ClinVar (Variation ID: 15889) and is found in the non- Finnish European population with an allele frequency of 0.06% (44/70302 alleles) in the Genome Aggregation Database. The glycine at codon 52 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.772). Based on available information, the p.Gly52Ser variant is considered to be likely benign. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/hbvar.html Scheps KG et al. Identification of a new HBA1 gene mutation (HBA1:c.301-2A>T) in cis with Hb Riccarton (HBA1:c.154G>A) (alpha51(CE9)Gly>Ser). Hemoglobin. 2012;36(5):504-7. PMID: 22738642 -

HEMOGLOBIN RICCARTON Other:1
Jul 20, 2016
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T;.
Eigen
Benign
0.0019
Eigen_PC
Benign
-0.032
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Pathogenic
0.68
D
MetaRNN
Uncertain
0.57
D;D
MetaSVM
Uncertain
0.68
D
PhyloP100
0.76
PrimateAI
Benign
0.40
T
PROVEAN
Pathogenic
-4.9
D;D
REVEL
Pathogenic
0.77
Sift
Uncertain
0.013
D;D
Sift4G
Uncertain
0.052
T;T
Vest4
0.43
MVP
1.0
ClinPred
0.67
D
GERP RS
3.3
PromoterAI
-0.012
Neutral
Varity_R
0.71
gMVP
0.81
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33960522; hg19: chr16-226986; API